Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
16%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
FTXH
50
HOLDINGS
27%
ALSO IN XPH
XPH
60
HOLDINGS
22%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 6.7% | 1.7% | 1.7% |
 |
JAZZ PHARMACEUTICALS PLC | 2.6% | 1.7% | 1.7% |
|
JOHNSON & JOHNSON | 7.1% | 1.7% | 1.7% |
|
MERCK & CO. INC. | 7.1% | 1.7% | 1.7% |
|
VIATRIS, INC. | 3.9% | 1.7% | 1.7% |
FTXH Overweight Relative to XPH
|
ABBVIE INC | 7.5% |
|
ELI LILLY & CO | 6.0% |
|
JOHNSON & JOHNSON | 5.5% |
|
MERCK & CO. INC. | 5.5% |
|
BRISTOL-MYERS SQUIBB CO | 5.0% |
|
BIOGEN IDEC INC | 3.5% |
|
CARDINAL HEALTH INC | 3.4% |
|
AMGEN INC | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 3.2% |
|
GILEAD SCIENCES INC | 2.9% |
FTXH Underweight Relative to XPH
|
CRINETICS PHARMACEUTICALS INC | -3.7% |
|
MBX BIOSCIENCES INC | -3.0% |
|
DEFINIUM THERAPEUTICS INC | -2.8% |
|
ENLIVEN THERAPEUTICS, INC. | -2.2% |
|
NUVATION BIO INC CLASS A | -2.1% |
|
ALUMIS INC | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.0% |
|
TREVI THERAPEUTICS, INC. | -2.0% |
|
EDGEWISE THERAPEUTICS, INC. | -1.9% |